Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-08-18

FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for aripiprazole from Apotex Corp., authorizing a generic version of the drug. This action represents a routine approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aripiprazole (generic) (ARIPIPRAZOLE)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)